REPL
Replimune Group Inc.
Company Overview
| Mkt Cap | $686.89M | Price | $9.73 |
| Volume | 2.33M | Change | -5.07% |
| P/E Ratio | -2.8 | Open | $10.24 |
| Revenue | -- | Prev Close | $10.25 |
| Net Income | $-247.3M | 52W Range | $2.68 - $17.00 |
| Div Yield | N/A | Target | $10.43 |
| Overall | 51 | Value | 60 |
| Quality | 23 | Technical | 72 |
No chart data available
Stock Overview
Updated DailyReplimune Group Inc. (REPL) is a leading Healthcare company in the Biotechnology industry, currently trading at $9.73 with a market capitalization of $686.89 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows REPL with a volume of 2.33 million shares. The stock opened down 0.10% from yesterday's close of $10.25. Current analyst estimates project earnings of $-3.36 per share for this year, with next year targeting $-1.95.
REPL demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for REPL include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 7.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:17 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REPL | $9.73 | -5.1% | 2.33M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |